An Observational Study of Bevacizumab-Induced Hypertension as a Clinical Biomarker of Antitumor Activity

BACKGROUND. Hypertension is a common toxicity of bevacizumab, but the frequency of assessment of blood pressure and standardized grading remain to be defined. This study aimed to describe the incidence of bevacizumab-induced hypertension and factors associated with its development, then to retrospec...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Mir, Olivier, Coriat, Romain, Cabanes, Laure, Ropert, Stanislas, Billemont, Bertrand, Alexandre, Jérôme, Durand, Jean-Philippe, Treluyer, Jean-Marc, Knebelmann, Bertrand, Goldwasser, François
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: AlphaMed Press 2011
Onderwerpen:
Symptom Management and Supportive Care
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228164/
https://ncbi.nlm.nih.gov/pubmed/21807768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0002
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items